In The Market Today

COVID-19 stocks.

This morning has proven to be a very exciting morning in the market with news across all categories. Here are some of the biggest moves that we’ve seen in the market today:

Clovis Oncology (NASDAQ: CLVS) – Clovis Oncology is running for the top after the FDA granted priority review for Rubraca. If approved, the drug will be one of very few options in a market that’s worth billions. As such, this could be a blockbuster drug. Read the full story at Alpha Stock News.

Nio Inc (NYSE: NIO) – Nio is climbing on strong volume after the company reported that it has secured funding. The company now has access to about $1 billion. Read the full story at MarketWatch.

Cemtrex Inc (NASDAQ: CETX) – Cemtrex saw serious gains this morning after announcing that it received a $700,000 order for surveillance equipment. The order was substantial as its value was more than 10% of the company’s market cap as of the closing bell yesterday. Read the full story at Alpha Stock News.

OrganiGram Holdings Inc (NASDAQ: OGI) – OrganiGram is climbing after posting strong financial results. With revenues up over 100% investors are excited. Read the full story at Investopedia.

Monumenta Pharmaceuticals, Inc (NASDAQ: MNTA) – Finally, Monumenta Pharmaceuticals is seeing strong gains after announcing pipeline updates. Read the full story at Yahoo! Finance.

Previous articleMistakes For Beginner Investors To Avoid
Next articleiBio (IBIO) Stock Will Not Undergo A Reverse Split
Hey, Im Joshua, the founder of CNA Finance. I enjoy following the trends in the market and finding the catalysts that are making the moves. If you want to get in contact with me, leave a comment below or email me at Please keep in mind that I am not an investment advisor and nor is CNA Finance. This is a news and information gathering outlet. We may work directly with some of the companies that we write about. If we have a business relationship with an issuer, we will mention that in the articles. We also have various affiliate relationships with advertisers and may be paid if you sign up for a service that you were referred to through our website.


Please enter your comment!
Please enter your name here